SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$226,000
-0.4%
18,100
-39.5%
0.00%0.0%
Q1 2022$227,000
-74.8%
29,910
-66.1%
0.00%
-83.3%
Q4 2021$902,000
+34.4%
88,330
+76.6%
0.02%
+100.0%
Q3 2021$671,000
-39.6%
50,020
+8.3%
0.01%
-36.8%
Q1 2021$1,111,00046,1800.02%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MPM BioImpact LLC 650,000$3,529,5000.92%
CHI Advisors LLC 333,945$1,813,3210.48%
PVG ASSET MANAGEMENT CORP 15,585$84,6260.37%
Rhenman & Partners Asset Management AB 370,000$2,009,1000.21%
NEEDHAM INVESTMENT MANAGEMENT LLC 184,000$999,1200.18%
Birchview Capital, LP 40,000$2170.15%
XTX Topco Ltd 102,282$555,3910.12%
Tekla Capital Management LLC 423,869$2,301,6090.09%
Woodline Partners LP 1,028,967$5,587,2910.08%
Curi Wealth Management, LLC 81,009$439,8790.06%
View complete list of G1 THERAPEUTICS INC shareholders